Your browser doesn't support javascript.
loading
Population-based BRCA1/2 testing programmes are highly acceptable in the Jewish community: results of the JeneScreen Study.
Tiller, Jane M; Cousens, Nicole E; Kaur, Rajneesh; Rowley, Simone; Ko, Yi-An; Mahale, Sakshi; Bankier, Agnes; Meiser, Bettina; Barlow-Stewart, Kristine; Burnett, Leslie; Jacobs, Chris; James, Paul; Trainer, Alison; Neil, Suzanne; Campbell, Ian G; Andrews, Lesley; Delatycki, Martin.
Afiliação
  • Tiller JM; Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Cousens NE; Victorian Clinical Genetics Services, Parkville, Victoria, Australia.
  • Kaur R; Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
  • Rowley S; Hereditary Cancer Centre, Prince of Wales Hospital and Community Health Services, Randwick, New South Wales, Australia.
  • Ko YA; University of New South Wales, Sydney, New South Wales, Australia.
  • Mahale S; Sydney Medical School, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.
  • Bankier A; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.
  • Meiser B; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.
  • Barlow-Stewart K; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.
  • Burnett L; Royal Children's Hospital, Parkville, Victoria, Australia.
  • Jacobs C; Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
  • James P; The University of Sydney, Sydney, New South Wales, Australia.
  • Trainer A; Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
  • Neil S; Graduate School of Health, University of Technology Sydney, Sydney, New South Wales, Australia.
  • Campbell IG; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Andrews L; Genomic Medicine, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Delatycki M; Parkville Familial Cancer Centre, Peter MacCallum Cancer Institute, Parkville, Victoria, Australia.
J Med Genet ; 60(3): 265-273, 2023 03.
Article em En | MEDLINE | ID: mdl-36763037
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias Tipo de estudo: Prognostic_studies Limite: Female / Humans País/Região como assunto: Oceania Idioma: En Revista: J Med Genet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias Tipo de estudo: Prognostic_studies Limite: Female / Humans País/Região como assunto: Oceania Idioma: En Revista: J Med Genet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália